Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Drug Dosing in Renal Diseases: Measurement of Glomerular Filtration Rate01:25

Drug Dosing in Renal Diseases: Measurement of Glomerular Filtration Rate

146
The glomerular filtration rate (GFR) is a critical indicator of kidney health, reflecting how well the kidneys filter blood. Changes in GFR can signal potential kidney impairment, necessitating accurate measurement methods to monitor kidney function effectively.Various molecules can serve as markers for GFR measurement, with the ideal marker meeting several specific criteria. It must freely filter at the glomerulus, avoid reabsorption or secretion by the renal tubules, remain unmetabolized, not...
146
Factors Affecting Renal Clearance: Renal Impairment01:17

Factors Affecting Renal Clearance: Renal Impairment

588
Renal dysfunction significantly impairs the renal clearance of drugs, leading to potential complications in drug therapy. Renal failure, which can be caused by various factors, poses a significant challenge in the elimination of drugs from the body.
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
588
Drug Dosing in Renal Diseases: Estimation of Glomerular Filtration Rate Based on Serum Creatinine Concentration01:28

Drug Dosing in Renal Diseases: Estimation of Glomerular Filtration Rate Based on Serum Creatinine Concentration

342
Glomerular filtration rate (GFR) can be estimated from serum creatinine using the modification of diet in renal disease (MDRD) formula or the chronic kidney disease–epidemiology collaboration (CKD–EPI) equation. Both methods are widely used in clinical practice to assess kidney function and guide treatment decisions.The MDRD equation does not require weight or height measurements and is normalized to the body surface area of 1.73 m², considered the average adult surface area.
342
Chronic Kidney Disease III: Interprofessional Care01:28

Chronic Kidney Disease III: Interprofessional Care

706
Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
706
Drug Dosing in Renal Diseases: Dose Adjustments Based on Drug Clearance and Elimination Rate Constant01:25

Drug Dosing in Renal Diseases: Dose Adjustments Based on Drug Clearance and Elimination Rate Constant

374
In patients with renal disease, dosage adjustments are necessary to maintain therapeutic plasma drug concentrations and prevent toxicity or subtherapeutic exposure. Renal impairment alters drug pharmacokinetics, especially in conditions like uremia, where changes such as prolonged elimination half-life and altered apparent volume of distribution can significantly affect drug disposition. These changes require careful modification of the dosing regimen to achieve the desired clinical...
374
Acute Kidney Injury IV: Diagnostic Studies and Prevention01:30

Acute Kidney Injury IV: Diagnostic Studies and Prevention

582
Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
582

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Pain-centered symptom-language co-occurrence networks differ between interstitial cystitis/bladder pain syndrome and fibromyalgia in Reddit patient discourse.

Scientific reports·2026
Same author

Enhancing Continence Recovery After Robot-Assisted Radical Prostatectomy: A Novel Combined Approach Using Testosterone Therapy and Magnetic Stimulation.

The Prostate·2026
Same author

Nationwide epidemiological survey of autosomal dominant polycystic kidney disease in Japan in 2022.

Clinical and experimental nephrology·2026
Same author

In Older Men With Persistent Nocturia Due to Nocturnal Polyuria, Desmopressin Is Effective for Those With Higher Muscle Mass.

Lower urinary tract symptoms·2026
Same author

Prevalence and prognostic impact of cancer cachexia in patients with bladder cancer: a multicenter retrospective study.

International journal of clinical oncology·2026
Same author

System-level clustering of testosterone-related biomarkers identifies high-risk aging profiles linked to inflammation and renal function.

Communications medicine·2026
Same journal

[A case of renal Fanconi syndrome due to Bence Jones' protein K-type multiple myeloma].

Nihon Jinzo Gakkai shi·2019
Same journal

[Association of blood pressure control effects on renal impairment with urinary protein: a study on the validity of the Japanese Society of Hypertension Guidelines for Management of Hypertension 2014].

Nihon Jinzo Gakkai shi·2019
Same journal

[Contrast-induced nephropathy].

Nihon Jinzo Gakkai shi·2019
Same journal

[Immunosuppressants-induced kidney injury].

Nihon Jinzo Gakkai shi·2019
Same journal

[Drug-induced kidney injury due to antibiotic agents].

Nihon Jinzo Gakkai shi·2019
Same journal

[Drug-induced kidney injury of anticancer chemotherapeutic drugs].

Nihon Jinzo Gakkai shi·2019
See all related articles

Related Experiment Video

Updated: May 5, 2026

Use of Ultra-high Field MRI in Small Rodent Models of Polycystic Kidney Disease for In Vivo Phenotyping and Drug Monitoring
07:35

Use of Ultra-high Field MRI in Small Rodent Models of Polycystic Kidney Disease for In Vivo Phenotyping and Drug Monitoring

Published on: June 23, 2015

10.9K

[Kidney volume and renal function in ADPKD]

Shigeo Horie, Satoru Muto

    Nihon Jinzo Gakkai Shi
    |November 19, 2013
    PubMed
    Summary

    No abstract available in PubMed .

    More Related Videos

    Use of 3D Robotic Ultrasound for In Vivo Analysis of Mouse Kidneys
    08:21

    Use of 3D Robotic Ultrasound for In Vivo Analysis of Mouse Kidneys

    Published on: August 12, 2021

    5.3K
    Assessment of Kidney Function in Mouse Models of Glomerular Disease
    09:16

    Assessment of Kidney Function in Mouse Models of Glomerular Disease

    Published on: June 30, 2018

    21.0K

    Related Experiment Videos

    Last Updated: May 5, 2026

    Use of Ultra-high Field MRI in Small Rodent Models of Polycystic Kidney Disease for In Vivo Phenotyping and Drug Monitoring
    07:35

    Use of Ultra-high Field MRI in Small Rodent Models of Polycystic Kidney Disease for In Vivo Phenotyping and Drug Monitoring

    Published on: June 23, 2015

    10.9K
    Use of 3D Robotic Ultrasound for In Vivo Analysis of Mouse Kidneys
    08:21

    Use of 3D Robotic Ultrasound for In Vivo Analysis of Mouse Kidneys

    Published on: August 12, 2021

    5.3K
    Assessment of Kidney Function in Mouse Models of Glomerular Disease
    09:16

    Assessment of Kidney Function in Mouse Models of Glomerular Disease

    Published on: June 30, 2018

    21.0K